Verity Asset Management, Inc.

Position in ABBV — AbbVie Inc.

CIK 1597298 DURHAM, NC

Position in ABBV

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$681,189

+$63,953 QoQ

Shares Held

2,707

-4.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.41%

of 13F equity value

Holder Rank

#2,896

of 4,153 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Verity Asset Management, Inc. holds $13,024,966 across 11 Drug Manufacturers - General names. ABBV ranks #8 (5.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	8,729	$3,160,945
2	BMY	Bristol Myers Squibb Co	31,404	$1,809,498
3	JNJ	Johnson & Johnson	5,968	$1,515,692
4	GSK	GSK plc	25,025	$1,311,810
5	GILD	Gilead Sciences, Inc.	10,134	$1,280,329
6	MRK	Merck & Co., Inc.	8,942	$1,149,047
7	LLY	ELI LILLY & Co	569	$682,475
8	ABBV	AbbVie Inc. This page	2,707	$681,189

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$681,189	2,707	-4.6%	Shares	Sole	2026-08-13
2026-03-31	$617,236	2,838	+0.7%	Shares	Sole	2026-04-21
2025-12-31	$643,884	2,818	+5.9%	Shares	Sole	2026-01-30
2025-09-30	$616,359	2,662	-0.1%	Shares	Sole	2025-11-14
2025-06-30	$494,491	2,664	+12.9%	Shares	Sole	2025-08-05
2025-03-31	$494,257	2,359	+12.4%	Shares	Sole	2025-04-25
2024-12-31	$372,814	2,098	+19.6%	Shares	Sole	2025-01-27
2024-09-30	$346,379	1,754	+7.1%	Shares	Sole	2024-10-31
2024-06-30	$280,949	1,638	+9.9%	Shares	Sole	2024-08-08
2024-03-31	$271,329	1,490	-0.1%	Shares	Sole	2024-05-28
2023-12-31	$231,060	1,491	—	Shares	Sole	2024-02-08
No filing history on record for this holder in this stock.